Recursion and Exscientia Partner to Create Trans-Atlantic AI Powerhouse for Drug Development
11/21/24, 2:46 AM
Location
salt lake cityMoney
$688 million
Industry
biotechnology
health care
Type
partnership
Recursion and Exscientia have completed a business combination to enhance their ability to carry out drug discovery that is both first-in-class and best-in-class. The deal includes a pipeline of more than 10 clinical and preclinical programs, 10 programs in advanced discovery phases, and more than 10 additional programs partnered with biopharmas, with a focus on oncology and rare diseases.
Company Info
Location
salt lake city, utah, united states
Additional Info
We are a clinical-stage TechBio company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery.
We are leveraging new technology to create virtuous cycles of learning around datasets to build the next-generation biopharmaceutical company. It’s complex biology, decoded.
While we are united in a common mission, Decoding Biology to Radically Improve Lives, our greatest strength lies in our differences: expertise, gender, race, disciplines, experience, and perspectives. Deliberately building and cultivating this culture is critical to achieving our audacious goals. We are proudly headquartered in Salt Lake City.